These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

690 related articles for article (PubMed ID: 23317655)

  • 1. Thinner choroid and greater drusen extent in retinal angiomatous proliferation than in typical exudative age-related macular degeneration.
    Kim JH; Kim JR; Kang SW; Kim SJ; Ha HS
    Am J Ophthalmol; 2013 Apr; 155(4):743-9, 749.e1-2. PubMed ID: 23317655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subfoveal choroidal thickness as a potential predictor of visual outcome and treatment response after intravitreal ranibizumab injections for typical exudative age-related macular degeneration.
    Kang HM; Kwon HJ; Yi JH; Lee CS; Lee SC
    Am J Ophthalmol; 2014 May; 157(5):1013-21. PubMed ID: 24487050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study.
    Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR
    Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subfoveal choroidal thickness in retinal angiomatous proliferation.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Retina; 2014 Jul; 34(7):1316-22. PubMed ID: 24406386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subfoveal choroidal thickness changes after intravitreal ranibizumab and photodynamic therapy for retinal angiomatous proliferation.
    Maruko I; Iida T; Oyamada H; Sugano Y; Saito M; Sekiryu T
    Retina; 2015 Apr; 35(4):648-54. PubMed ID: 25627088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Segregation of ophthalmoscopic characteristics according to choroidal thickness in patients with early age-related macular degeneration.
    Switzer DW; Mendonça LS; Saito M; Zweifel SA; Spaide RF
    Retina; 2012 Jul; 32(7):1265-71. PubMed ID: 22222760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small retinal haemorrhages accompanied by macular soft drusen: prevalence, and funduscopic and angiographic characteristics.
    Kim JH; Lee TG; Kim JW; Kim CG; Cho SW; Han JI
    Br J Ophthalmol; 2014 Aug; 98(8):1066-72. PubMed ID: 24659351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macular choroidal thickness and volume of eyes with reticular pseudodrusen using swept-source optical coherence tomography.
    Ueda-Arakawa N; Ooto S; Ellabban AA; Takahashi A; Oishi A; Tamura H; Yamashiro K; Tsujikawa A; Yoshimura N
    Am J Ophthalmol; 2014 May; 157(5):994-1004. PubMed ID: 24491418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and clinical factors associated with reticular pseudodrusen in exudative age-related macular degeneration.
    Yoneyama S; Sakurada Y; Mabuchi F; Imasawa M; Sugiyama A; Kubota T; Iijima H
    Graefes Arch Clin Exp Ophthalmol; 2014 Sep; 252(9):1435-41. PubMed ID: 24595987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subfoveal Choroidal Thickness during Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: Twelve-Month Results.
    Koizumi H; Kano M; Yamamoto A; Saito M; Maruko I; Sekiryu T; Okada AA; Iida T
    Ophthalmology; 2016 Mar; 123(3):617-24. PubMed ID: 26686967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularization.
    Kim JH; Chang YS; Kim JW; Kim CG; Yoo SJ; Cho HJ
    Ophthalmology; 2014 Apr; 121(4):926-35. PubMed ID: 24342019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy.
    Jirarattanasopa P; Ooto S; Nakata I; Tsujikawa A; Yamashiro K; Oishi A; Yoshimura N
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3663-72. PubMed ID: 22570352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Choroidal Thickness Changes in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy: A 12-Month Prospective Study.
    Ting DS; Ng WY; Ng SR; Tan SP; Yeo IY; Mathur R; Chan CM; Tan AC; Tan GS; Wong TY; Cheung CM
    Am J Ophthalmol; 2016 Apr; 164():128-36.e1. PubMed ID: 26743619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of age-related macular degeneration on macular thickness measurement made with fourier-domain optical coherence tomography.
    Garas A; Papp A; Holló G
    J Glaucoma; 2013 Mar; 22(3):195-200. PubMed ID: 22314250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
    Punjabi OS; Huang J; Rodriguez L; Lyon AT; Jampol LM; Mirza RG
    Br J Ophthalmol; 2013 Aug; 97(8):1024-31. PubMed ID: 23759437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of macular choroidal thickness in adult onset foveomacular vitelliform dystrophy and age-related macular degeneration.
    Coscas F; Puche N; Coscas G; Srour M; Français C; Glacet-Bernard A; Querques G; Souied EH
    Invest Ophthalmol Vis Sci; 2014 Jan; 55(1):64-9. PubMed ID: 24282233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subfoveal Choroidal Thickness in Eyes with Neovascular Age-Related Macular Degeneration Treated with Anti-Vascular Endothelial Growth Factor Agents.
    Kanadani TCM; Veloso CE; Nehemy MB
    Ophthalmologica; 2018; 240(4):200-207. PubMed ID: 29768266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multimodal imaging of early stage 1 type 3 neovascularization with simultaneous eye-tracked spectral-domain optical coherence tomography and high-speed real-time angiography.
    Querques G; Souied EH; Freund KB
    Retina; 2013 Oct; 33(9):1881-7. PubMed ID: 23644560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.